111

111 Documents

Documents

96

Ticker

YI

ISIN

US68247Q2012

Revenue Net Income P/E P/S EBIT Dividend Directors Dealings Stocks Market capitalization Debt Liabilities Equity AAQS Employees ROE ROA ROCE News Documents

111 SEC Filings

Type
Report
Date
33-Formular3/19/2026
33-Formular3/18/2026
33-Formular3/18/2026
6-K6-K-Formular12/17/2025
6-K6-K-Formular9/17/2025
20-F/A20-F/A-Formular8/29/2025
6-K6-K-Formular6/20/2025
20-F20-F-Formular4/29/2025
6-K6-K-Formular3/20/2025
6-K6-K-Formular2/11/2025
6-K6-K-Formular1/8/2025
6-K6-K-Formular11/27/2024
6-K6-K-Formular11/4/2024
6-K6-K-Formular8/29/2024
6-K6-K-Formular7/19/2024
6-K6-K-Formular5/23/2024
20-F20-F-Formular5/14/2024
NT 20-FNT 20-F-Formular4/30/2024
6-K6-K-Formular3/21/2024
SC 13D/ASC 13D/A-Formular2/27/2024
6-K6-K-Formular2/27/2024
6-K6-K-Formular11/30/2023
6-K6-K-Formular8/24/2023
UPLOADUPLOAD-Formular8/14/2023
CORRESPCORRESP-Formular8/1/2023
UPLOADUPLOAD-Formular7/21/2023
SC 13D/ASC 13D/A-Formular7/17/2023
6-K6-K-Formular6/15/2023
20-F20-F-Formular4/28/2023
6-K6-K-Formular3/23/2023
6-K6-K-Formular12/1/2022
SC 13D/ASC 13D/A-Formular10/31/2022
6-K6-K-Formular9/23/2022
SC 13DSC 13D-Formular9/9/2022
6-K6-K-Formular9/9/2022
6-K6-K-Formular8/25/2022
6-K6-K-Formular6/16/2022
6-K6-K-Formular5/5/2022
20-F20-F-Formular4/29/2022
6-K6-K-Formular3/17/2022
6-K6-K-Formular3/1/2022
SC 13G/ABeneficial ownership report2/10/2022
6-K6-K-Formular11/19/2021
6-K6-K-Formular9/7/2021
6-K6-K-Formular8/27/2021
SC 13G/ABeneficial ownership report5/27/2021
6-K6-K-Formular5/19/2021
20-F20-F-Formular4/30/2021
6-K6-K-Formular3/18/2021
SC 13G/ABeneficial ownership report2/5/2021
6-K6-K-Formular12/22/2020
6-K6-K-Formular11/19/2020
6-K6-K-Formular11/6/2020
6-K6-K-Formular8/20/2020
6-K6-K-Formular5/21/2020
20-F20-F-Formular4/16/2020
6-K6-K-Formular3/13/2020
SC 13G/ABeneficial ownership report2/24/2020
SC 13G/ABeneficial ownership report1/29/2020
6-K6-K-Formular11/15/2019
6-K6-K-Formular8/19/2019
6-K6-K-Formular5/17/2019
6-K6-K-Formular5/16/2019
20-F20-F-Formular4/10/2019
6-K6-K-Formular3/8/2019
6-K6-K-Formular2/27/2019
SC 13GSC 13G-Formular2/14/2019
SC 13GSC 13G-Formular2/11/2019
SC 13GSC 13G-Formular1/28/2019
SC 13GSC 13G-Formular1/28/2019
S-8S-8-Formular1/22/2019
SC 13GSC 13G-Formular1/18/2019
6-K6-K-Formular1/18/2019
6-K6-K-Formular11/9/2018
424B4424B4-Formular9/13/2018
EFFECTEFFECT-Formular9/12/2018
CORRESPCORRESP-Formular9/7/2018
CORRESPCORRESP-Formular9/7/2018
FWPFWP-Formular9/7/2018
CORRESPCORRESP-Formular9/7/2018
F-1/AF-1/A-Formular9/7/2018
UPLOADUPLOAD-Formular9/5/2018
CERTCERT-Formular9/4/2018
CORRESPCORRESP-Formular8/29/2018
F-1/AF-1/A-Formular8/29/2018
8-A12B8-A12B-Formular8/29/2018
CORRESPCORRESP-Formular8/15/2018
F-1F-1-Formular8/15/2018
DRS/ADRS/A-Formular7/27/2018
DRSLTRDRSLTR-Formular7/27/2018
UPLOADUPLOAD-Formular7/9/2018
DRSLTRDRSLTR-Formular6/26/2018
DRS/ADRS/A-Formular6/26/2018
UPLOADUPLOAD-Formular6/14/2018
DRSDRS-Formular5/17/2018
DRSLTRDRSLTR-Formular5/17/2018

111 Documents 2026

This page contains all official documents and SEC filings for 111 stock (YI, ISIN: US68247Q2012). This includes annual reports (Form 10-K), quarterly reports (Form 10-Q), and insider transactions (Form 4). Currently 96 documents are available. Data is updated regularly to provide investors with a complete overview of 111's regulatory filings.

111 Stock analysis

111 111 Inc, trading under the ticker YI and ISIN US68247Q2012, is a company based in Shanghai, China, operating within the Consumer Staples sector and Retail industry. The company went public on September 12, 2018. According to the provided information, 111 Inc is engaged in the provision of pharmaceutical products and medical services through online retail pharmacy and an indirect offline pharmacy network. The company's website is http://gangling.111.com.cn/. The employee count provided in the user message is 144, though the source description mentions 1,932 full-time employees, which is inconsistent. The company focuses on online medical services, drug purchasing, and health management services utilizing internet and information technology. It primarily serves the domestic market in China. The company's headquarters are located in Shanghai, Shanghai, and it operates with a focus on retail and consumer staples within the pharmaceutical and healthcare services domain.